Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:René_Salas
|
| gptkbp:focusesOn |
treatment of neurological disorders
treatment of essential tremor |
| gptkbp:foundedYear |
2014
|
| gptkbp:founder |
gptkb:Kate_Rosenbluth
|
| gptkbp:headquartersLocation |
gptkb:Burlingame,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cala Health
|
| gptkbp:industry |
medical device
|
| gptkbp:investor |
gptkb:Lightstone_Ventures
gptkb:Novartis gptkb:Johnson_&_Johnson_Innovation GV (formerly Google Ventures) |
| gptkbp:product |
gptkb:Cala_Trio
gptkb:Cala_kIQ |
| gptkbp:receivedFDAApproval |
gptkb:Cala_Trio
|
| gptkbp:specializesIn |
wearable neuromodulation therapies
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.calahealth.com/
|
| gptkbp:bfsParent |
gptkb:Osage_University_Partners
|
| gptkbp:bfsLayer |
6
|